KalVista Pharmaceuticals (KALV) Stock Chart & Stock Price History $10.61 +0.34 (+3.31%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends KalVista Pharmaceuticals Stock Price Performance5 Day Performance-12.24%1 Month Performance-10.39%3 Month Performance-19.44%6 Month Performance-12.82%Year-To-Date Performance-13.39%1 Year Performance+22.45% Receive KALV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why KALV Stock Chart for Saturday, November, 2, 2024 KALV Chart by TradingView KalVista Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$10.27$10.61+3.31%$10.72$10.22281,256 shs$458.51 million10/31/2024$11.20$10.27-8.30%$11.42$10.01493,166 shs$433.27 million10/30/2024$11.79$11.20-5.00%$11.81$11.1788,564 shs$472.51 million10/29/2024$12.09$11.79-2.48%$12.15$11.6392,000 shs$497.40 million10/28/2024$11.68$12.09+3.51%$12.33$11.77107,762 shs$510.05 million10/25/2024$12.07$11.68-3.23%$12.23$11.68119,130 shs$492.76 million Get the Latest News and Ratings for KALV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$12.01$12.07+0.50%$12.14$11.77300,137 shs$509.21 million10/23/2024$12.35$12.01-2.75%$12.42$11.83199,167 shs$506.68 million10/22/2024$12.32$12.35+0.24%$12.40$12.0592,270 shs$521.02 million10/21/2024$12.50$12.32-1.44%$12.50$12.17107,875 shs$519.76 million10/18/2024$12.09$12.50+3.39%$12.52$12.10119,196 shs$527.35 million10/17/2024$12.33$12.09-1.95%$12.31$11.98127,877 shs$510.05 million10/16/2024$11.98$12.33+2.92%$12.50$11.93251,731 shs$520.18 million10/15/2024$11.72$11.98+2.22%$12.03$11.47176,548 shs$505.41 million10/14/2024$11.63$11.72+0.77%$11.75$11.45129,901 shs$494.44 million10/11/2024$10.99$11.63+5.82%$11.67$10.95193,883 shs$502.65 million10/10/2024$11.24$10.99-2.22%$11.20$10.84257,782 shs$463.65 million10/09/2024$11.21$11.24+0.27%$11.41$11.02310,928 shs$474.19 million10/08/2024$11.28$11.21-0.62%$11.58$11.11265,631 shs$472.93 million10/07/2024$11.36$11.28-0.70%$11.37$11.11210,817 shs$475.88 million10/04/2024$11.54$11.36-1.56%$11.82$11.18448,251 shs$479.26 million10/03/2024$11.84$11.54-2.53%$11.98$11.54182,964 shs$486.85 million10/02/2024$11.39$11.84+3.95%$11.86$11.27564,049 shs$499.51 million10/01/2024$11.58$11.39-1.64%$11.56$10.931.10 million shs$480.52 million09/30/2024$12.34$11.58-6.16%$12.55$11.44692,677 shs$488.54 million09/27/2024$10.00$12.34+23.40%$12.36$10.261.83 million shs$520.60 million09/26/2024$9.46$10.00+5.71%$10.03$9.48394,886 shs$421.88 million09/25/2024$9.65$9.46-1.97%$9.83$9.45201,854 shs$408.86 million09/24/2024$9.78$9.65-1.33%$9.96$9.62247,373 shs$407.11 million09/23/2024$10.49$9.78-6.77%$10.57$9.78264,153 shs$412.60 million09/20/2024$11.00$10.49-4.64%$10.99$10.392.08 million shs$442.55 million09/19/2024$10.69$11.00+2.90%$11.23$10.76272,047 shs$464.07 million09/18/2024$10.57$10.69+1.14%$10.96$10.55249,368 shs$450.99 million09/17/2024$10.77$10.57-1.86%$11.13$10.46763,330 shs$445.93 million09/16/2024$11.14$10.77-3.32%$11.25$10.52395,320 shs$465.48 million09/13/2024$10.46$11.14+6.50%$11.24$10.40427,762 shs$481.47 million09/12/2024$10.72$10.46-2.43%$10.89$10.44554,896 shs$441.29 million09/11/2024$11.21$10.72-4.37%$11.42$10.66319,181 shs$463.32 million09/10/2024$11.87$11.21-5.56%$12.00$11.19556,002 shs$484.50 million09/09/2024$12.34$11.87-3.81%$12.81$11.72350,859 shs$513.02 millionWe recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.09/06/2024$12.87$12.34-4.12%$13.14$12.23234,664 shs$520.60 million09/05/2024$12.92$12.87-0.39%$13.10$12.60223,263 shs$542.96 million09/04/2024$12.37$12.92+4.45%$13.03$12.26197,177 shs$545.07 million09/03/2024$13.39$12.37-7.62%$13.52$12.14252,441 shs$521.87 million09/02/2024$13.39$13.39$13.47$12.68725,100 shs$576.84 million08/30/2024$13.00$13.39+3.00%$13.47$12.68725,195 shs$564.90 million08/29/2024$12.89$13.00+0.85%$13.33$12.86189,266 shs$548.44 million08/28/2024$12.68$12.89+1.66%$13.03$12.54214,335 shs$543.80 million08/27/2024$13.06$12.68-2.91%$13.04$12.42352,972 shs$534.94 million08/26/2024$12.63$13.06+3.40%$13.09$12.57150,005 shs$550.98 million08/23/2024$12.42$12.63+1.69%$12.69$12.33168,946 shs$532.83 million08/22/2024$12.58$12.42-1.27%$12.56$12.14154,240 shs$523.98 million08/21/2024$12.52$12.58+0.52%$12.75$12.23169,530 shs$530.73 million08/20/2024$12.24$12.52+2.25%$12.71$12.12156,003 shs$527.98 million08/19/2024$12.00$12.24+2.00%$12.35$11.44526,711 shs$516.38 million08/16/2024$12.79$12.00-6.18%$12.77$11.84539,754 shs$506.26 million08/15/2024$12.49$12.79+2.40%$13.16$12.53179,069 shs$539.59 million08/14/2024$12.98$12.49-3.78%$13.13$12.48159,600 shs$526.93 million08/13/2024$12.97$12.98+0.08%$13.17$12.88129,962 shs$547.60 million08/12/2024$12.90$12.97+0.54%$13.27$12.77126,821 shs$547.18 million08/09/2024$13.05$12.90-1.15%$13.15$12.83133,892 shs$544.23 million08/08/2024$12.50$13.05+4.40%$13.14$12.5488,654 shs$550.55 million08/07/2024$12.95$12.50-3.47%$13.21$12.47145,111 shs$527.35 million08/06/2024$12.79$12.95+1.25%$13.16$12.81205,044 shs$553.48 million08/05/2024$13.17$12.79-2.89%$12.88$12.11239,291 shs$546.65 million08/02/2024$13.83$13.17-4.77%$13.55$12.99160,738 shs$555.62 million08/01/2024$14.54$13.83-4.88%$14.84$13.79407,780 shs$591.09 million Related Companies ABUS Stock Price Chart BYSI Stock Price Chart BCRX Stock Price Chart AKRO Stock Price Chart NTLA Stock Price Chart VCEL Stock Price Chart GLPG Stock Price Chart HRMY Stock Price Chart KNSA Stock Price Chart MIRM Stock Price Chart Receive KALV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KALV) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KalVista Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KalVista Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
